Showing results (141-150 of 199) with videos related to
Sort By:
Pageof 20
Nature Communications|September 6, 2012
Discovery of acetylene hydratase activity of the iron-sulphur protein IspHIngrid Span, Ke Wang, Weixue Wang, et al.Nature Communications|May 6, 2018
Structure and mechanism of the two-component α-helical pore-forming toxin YaxABBastian Bräuning, Eva Bertosin, Florian Praetorius, et al.Journal of Medicinal Chemistry|January 8, 2026
Structure-Based Design of Pan-Selective Peptide Epoxyketones for the Three Human Immunoproteasome Active SitesPatrick M Dekker, Eva M Huber, Elmer Maurits, et al.Angewandte Chemie (International Ed. in English)|September 23, 2014
Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active siteChristian Dubiella, Haissi Cui, Malte Gersch, et al.European Journal of Medicinal Chemistry|August 31, 2018
Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitorsDoleshwar Niroula, Liam P Hallada, Camille Le Chapelain, et al.Angewandte Chemie (International Ed. in English)|March 5, 2014
Harnessing the evolvability of tricyclic microviridins to dissect protease-inhibitor interactionsAnnika R Weiz, Keishi Ishida, Felix Quitterer, et al.Nature|April 11, 2008
A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanismMichael Groll, Barbara Schellenberg, André S Bachmann, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|September 25, 2014
Receptor-bound conformation of cilengitide better represented by its solution-state structure than the solid-state structureUdaya Kiran Marelli, Andreas O Frank, Bernhard Wahl, et al.ACS Chemical Biology|July 8, 2017
Mechanism of Allosteric Inhibition of the Enzyme IspD by Three Different Classes of LigandsAnatol Schwab, Boris Illarionov, Annika Frank, et al.Nature|May 24, 2008
Ubiquitin docking at the proteasome through a novel pleckstrin-homology domain interactionPatrick Schreiner, Xiang Chen, Koraljka Husnjak, et al.Pageof 20